WHO世界卫生组织：2024年第5号新闻通讯报告（英文版）

The Therapeutic Goods Administration (TGA) has updated warning about the risk of sudden cardiovascular death to the Product Information (PI) and Consumer Medicine Information (CMI) documents for azithromycin. Azithromycin is indicated for mild to moderate infections in adults, including upper and lower respiratory tract infections, as well as uncomplicated skin and skin structure infections, among others. Azithromycin already carried a warning of ventricular arrhythmias associated with prolon